文献速递心境障碍

预测抑郁症复发或再发的预后模型:系统综述

Predicting relapse or recurrence of depression: systematic review of prognostic models.
PubMed 文献 · Br J Psychiatry · 2022-01-01

该系统综述检索截至2021年5月的多个数据库,纳入12项预后模型研究(11个独特模型),其中8项仅为模型开发、3项开发加外部验证、1项仅外部验证。12项研究中11项总体偏倚风险高,且无研究评估临床效用;作者结论为现有模型尚不足以用于临床。

要点

  • 纳入12项研究共11个独特预后模型,仅1项为外部验证研究。
  • 12项研究中11项总体偏倚风险高,无研究评估临床效用。
  • 作者结论:现有模型预测性能不佳且外部验证有限,尚不足以用于临床。

核心结论

  • 由于纳入研究偏倚风险高、预测性能不佳且外部验证有限,目前可用的抑郁症复发和再发临床预测模型尚不足以用于临床环境。
  • 该领域需要改进预后研究,未来研究应遵循最佳实践方法和报告指南。

研究设计与样本

  • 系统综述,检索Cochrane Library当前期、Ovid MEDLINE(1946年起)、Ovid Embase(1980年起)、Ovid PsycINFO(1806年起)和Web of Science(1900年起),截至2021年5月。
  • 纳入多变量预后模型的开发研究和外部验证研究,共识别12项符合条件的预后模型研究(11个独特预后模型):8项仅为模型开发研究、3项模型开发加外部验证研究、1项仅外部验证研究。
  • 使用预测模型偏倚风险评估工具(PROBAST)评估纳入研究的偏倚风险。
  • 因无法获得性能指标的多次估计,未进行Meta分析。

主要发现

  • 12项纳入研究中11项被评估为总体偏倚风险高,无研究评估临床效用。
  • 无法获得性能指标的多次估计,因此未进行Meta分析。

临床怎么用

  • 作者结论:目前可用的抑郁症复发和再发临床预测模型尚不足以用于临床环境。

局限性

  • 12项纳入研究中11项被评估为总体偏倚风险高。
  • 无研究评估临床效用。
  • 无法获得性能指标的多次估计,因此未进行Meta分析。
  • 所识别模型的预测性能不佳且外部验证有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Relapse and recurrence of depression are common, contributing to the overall burden of depression globally. Accurate prediction of relapse or recurrence while patients are well would allow the identification of high-risk individuals and may effectively guide the allocation of interventions to prevent relapse and recurrence. AIMS: To review prognostic models developed to predict the risk of relapse, recurrence, sustained remission, or recovery in adults with remitted major depressive disorder. METHOD: We searched the Cochrane Library (current issue); Ovid MEDLINE (1946 onwards); Ovid Embase (1980 onwards); Ovid PsycINFO (1806 onwards); and Web of Science (1900 onwards) up to May 2021. We included development and external validation studies of multivariable prognostic models. We assessed risk of bias of included studies using the Prediction model risk of bias assessment tool (PROBAST). RESULTS: We identified 12 eligible prognostic model studies (11 unique prognostic models): 8 model development-only studies, 3 model development and external validation studies and 1 external validation-only study. Multiple estimates of performance measures were not available and meta-analysis was therefore not necessary. Eleven out of the 12 included studies were assessed as being at high overall risk of bias and none examined clinical utility. CONCLUSIONS: Due to high risk of bias of the included studies, poor predictive performance and limited external validation of the models identified, presently available clinical prediction models for relapse and recurrence of depression are not yet sufficiently developed for deploying in clinical settings. There is a need for improved prognosis research in this clinical area and future studies should conform to best practice methodological and reporting guidelines.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Moriarty AS, Meader N, Snell KIE, et al. Predicting relapse or recurrence of depression: systematic review of prognostic models. Br J Psychiatry. 2022. PMID: 35048843. doi:10.1192/bjp.2021.218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。